Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JHG
226
DELISTED
Janus Henderson
JHG
| $38.9M | 0.03% |
1,654,002
+415,185
| +34% | +$11.9M |
|
227
Pegasystems
PEGA
$5.23B
| $36.8M | 0.03% |
1,539,338
+90,474
| +6% | +$2.71M |
|
228
Vericel Corp
VCEL
$2.37B
| $36.3M | 0.03% |
1,439,863
+215,752
| +18% | +$6.37M |
|
229
Delek US
DK
$3.88B
| $36M | 0.03% |
1,394,562
-249,968
| -15% | -$6.75M |
|
|
NUVA
230
DELISTED
NuVasive, Inc.
NUVA
| $36M | 0.03% |
732,904
-17,370
| -2% | -$932K |
|
231
HubSpot
HUBS
$12.8B
| $35.7M | 0.03% |
118,704
+9,749
| +9% | +$3.56M |
|
232
Bilibili
BILI
$7.88B
| $35.6M | 0.03% |
1,392,389
-116,032
| -8% | -$2.79M |
|
233
Rockwell Automation
ROK
$50.9B
| $35.6M | 0.03% |
178,472
+14,670
| +9% | +$3.31M |
|
234
Nice
NICE
$5.62B
| $35.5M | 0.03% |
184,238
+402
| +0.2% | +$81.4K |
|
235
Lantheus
LNTH
$6.59B
| $34.8M | 0.02% |
526,716
-6,559
| -1% | -$413K |
|
236
Plexus
PLXS
$7.35B
| $34.7M | 0.02% |
442,477
-17,551
| -4% | -$1.42M |
|
|
ENV
237
DELISTED
ENVESTNET, INC.
ENV
| $34.1M | 0.02% |
646,326
+136,176
| +27% | +$9.31M |
|
238
Sociedad Química y Minera de Chile
SQM
$19.9B
| $33.4M | 0.02% |
+399,964
| New | +$35.2M |
|
239
Bristol-Myers Squibb
BMY
$130B
| $32.8M | 0.02% |
425,800
-4,011
| -0.9% | -$305K |
|
240
Gerdau
GGB
$9.99B
| $32.7M | 0.02% |
9,595,487
-1,977,118
| -17% | -$8.8M |
|
|
CADE
241
DELISTED
Cadence Bank
CADE
| $32M | 0.02% |
1,362,490
+274,139
| +25% | +$7.06M |
|
242
Honeywell
HON
$79.2B
| $31.9M | 0.02% |
194,874
-2,451
| -1% | -$440K |
|
243
Glacier Bancorp
GBCI
$6.6B
| $31.6M | 0.02% |
665,668
+67,660
| +11% | +$3.19M |
|
244
Integra LifeSciences
IART
$1.38B
| $31.2M | 0.02% |
577,979
-17,461
| -3% | -$1.05M |
|
245
EOG Resources
EOG
$73.1B
| $30.9M | 0.02% |
280,008
+9
| +0% | +$1.12K |
|
|
MZTI
246
The Marzetti Company
MZTI
$3B
| $30.9M | 0.02% |
239,951
-3,988
| -2% | -$546K |
|
247
WIX.com
WIX
$2.82B
| $30.3M | 0.02% |
462,905
+46,435
| +11% | +$3.4M |
|
248
UMB Financial
UMBF
$11.3B
| $30.2M | 0.02% |
350,904
+99,155
| +39% | +$8.99M |
|
249
Nucor
NUE
$63.5B
| $30M | 0.02% |
287,223
+38,681
| +16% | +$5.23M |
|
250
Veracyte
VCYT
$3.81B
| $29.4M | 0.02% |
1,475,285
+327,066
| +28% | +$6.61M |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.